Every day, we’re focused on doing our best work to address unmet medical needs while minimizing the impact on our environment. This means making the most of our shared resources so we can deliver more lifesaving medicines to patients.
The Green Chemistry movement is driven by scientists, researchers and engineers aiming to create alternative processes that protect and preserve natural resources while reducing toxic waste. At Gilead, it’s changing the way we produce lifesaving medicines in earth-friendly ways.
Incorporating Green Chemistry and other sustainability efforts across all phases of our R&D is a team effort. Here are some of the people making it possible:
“We believe that protecting the environment is integral to our mission, which is why we continuously strive to improve our environmental practices through conservation and pollution-prevention principles.” Joydeep Ganguly, SVP, Corporate Operations at Gilead
“In the new award-winning Gilead building, we’ve reduced energy usage by 35 to 40%.” Zhongxin Zhou, Executive Director, Process Development at Gilead
“Our sustainability journey started by evaluating where to best focus our efforts. Now we are implementing the principles of Green Chemistry to ensure the long-term sustainability of our operations.” Jonathan Tripp, Senior Research Scientist, Process Development at Gilead
From green buildings to renewable energy to responsible sourcing, our sustainability efforts are far-reaching and constantly evolving. We strive to provide a healthy and safe workplace evidenced by the strict environmental practices we hold true.
Reduce our global Scope 1 and 2 greenhouse gas emissions by 25% by 2025, compared with our 2016 emissions.
Participate in the ACS GCI Pharmaceutical Roundtable to encourage the innovation and integration of Green Chemistry within the industry.
Prioritize Green Chemistry protocols like the innovative use of enzymatic catalysis, flow chemistry and greener solvents in active pharmaceutical ingredient synthesis.
Through socially- and environmentally-responsible sourcing and production, we believe we can create more lifesaving medicines and improve access to them.
Monica Tijerina, Executive Director, Formulation and Process Development at Gilead
The work is already underway. Read Gilead’s 2019 Year in Review to learn more.
Download the Report
Mobile
